From 14c58bad5cb4933bd04a20cf0de0352672acb2ea Mon Sep 17 00:00:00 2001 From: borja Date: Thu, 5 Dec 2024 15:33:41 +0100 Subject: [PATCH] Auto saved by Logseq --- journals/2024_12_05.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/journals/2024_12_05.md b/journals/2024_12_05.md index 5b14a253..050bed9a 100644 --- a/journals/2024_12_05.md +++ b/journals/2024_12_05.md @@ -53,7 +53,7 @@ - AK: They may request additional data. We have started to revise a new version of the systematic review of high dose ivm during the pandemic. Registered in PROSPERO. When any news brought here. That would be useful - AB: We've missed the EoI deadline. I didn't know until recently that ALB and IVM arae in the EML, and ALB does specific mention of combination with IVM. It makes it a lot easier than other medicines that have to make from scratch the case that they should be added. We're quite a few steps along the way. - CV: Interim report, add it to the word document - - AL: Protocol 2.0 we received full approval from ERC and FDA. Kenya we have IRB, waiting for PPB. We have made some ammendments to the protocol. They have to be submitted to the countries. 3.0 pending submission. 4.0 it changes one of the inclusion criteria. + - AL: Protocol 2.0 we received full approval from ERC and FDA. Kenya we have IRB, waiting for PPB. We have made some ammendments to the protocol. They have to be submitted to the countries. 3.0 pending submission. 4.0 it changes one of the inclusion criteria. Se sube a 110cm para que sean 15kg. Setup and preparation at sponsor and site levels is continuing. Liconsa will work on the export permit. The product has been manufactured and the - ### Decisiones - TODO Añadir el interim report al documento de Word STOP2030 SCHEDULED: <2024-12-09 Mon>